Period of time: 2013年2期
Publisher: Future Medicine
Founded in: 2006
Total resources: 64
ISSN: 1746-0794
Subject: R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Future Virology,volume 7,issue 2
Menu
HIV-1 Nef: hacker of the host cell
By Saxena Shailendra K,Shrivastava Gaurav,Tiwari Sneham,Nair Madhavan PN in (2012)
Future Virology,volume 7,issue 2 , Vol. 7, Iss. 2, 2012-02 , pp.By Arbyn Marc,Gissmann Lutz,Schneider Achim,Kaufmann Andreas M in (2012)
Future Virology,volume 7,issue 2 , Vol. 7, Iss. 2, 2012-02 , pp.By Song Min,Bambara Robert A in (2012)
Future Virology,volume 7,issue 2 , Vol. 7, Iss. 2, 2012-02 , pp.Consequences of persistent HBV infection in HIV: the double-edged sword of nucleos(t)ide analogs
By Boyd Anders,Girard Pierre-Marie,Lacombe Karine in (2012)
Future Virology,volume 7,issue 2 , Vol. 7, Iss. 2, 2012-02 , pp.Progress in DNA vaccination against HBV infection
Future Virology,volume 7,issue 2 , Vol. 7, Iss. 2, 2012-02 , pp.By Feng Huixing,Zhang Jianhua,Tan Jane YL,Sadrolodabaee Laleh,Chen Wei Ning in (2012)
Future Virology,volume 7,issue 2 , Vol. 7, Iss. 2, 2012-02 , pp.Ross River virus evolution: implications for vaccine development
By Aaskov John,Fokine Andrei,Liu Wenjun in (2012)
Future Virology,volume 7,issue 2 , Vol. 7, Iss. 2, 2012-02 , pp.Viral subversion of host functions for picornavirus translation and RNA replication
By Chase Amanda J,Semler Bert L in (2012)
Future Virology,volume 7,issue 2 , Vol. 7, Iss. 2, 2012-02 , pp.Race and CD4+ T-cell count in HIV prognosis and treatment
By Achhra Amit C,Amin Janaki in (2012)
Future Virology,volume 7,issue 2 , Vol. 7, Iss. 2, 2012-02 , pp.